ID
38143
Descripción
Study ID: 111539 Clinical Study ID: 111539 Study Title: A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of scalating Repeat Doses of GSK249320 in Patients With Stroke Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00833989 https://clinicaltrials.gov/ct2/show/NCT00833989 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Refanezumab, Placebo Trade Name: N/A Study Indication: Ischaemic Attack, Transient The study consists of 8 visits: Day 1, Week 1 (Day 5), Week 2 (Day 10), Week 4 (Day 30), Week 8 (Day 60), Week 12 (Day 90), Week 16 (Day 112), Follow-up (F/U). All subjects will receive two doses. The first dose within 24-72 hrs after stroke the second dose 9 +/- 1 days after the first one. Each dose will be given as an intravenous infusion over 60 minutes. This document contains the concomitant medication form. It has to be filled in if concomitant medication has been taken by subject.
Link
https://clinicaltrials.gov/ct2/show/NCT00833989
Palabras clave
Versiones (2)
- 22/9/19 22/9/19 -
- 5/10/19 5/10/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
22 de septiembre de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety, Pharmacokinetics and Pharmacodynamics of Refanezumab in Patients with Stroke, 111539
Concomitant medication
- StudyEvent: ODM
Descripción
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Descripción
Sequence Number
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2348184
Descripción
(Trade Name preferred)
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2360065
- UMLS CUI [1,2]
- C2347852
Descripción
Total daily dose
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C2348070
- UMLS CUI [1,2]
- C2347852
Descripción
Units of concomitant medication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0439148
Descripción
Route of concomitant medication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826730
Descripción
Reason for Medication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826696
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2826734
Descripción
Concomitant medication prior to study
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1883727
- UMLS CUI [1,3]
- C0332152
- UMLS CUI [1,4]
- C2347804
Descripción
If you tick No, please specify End date in the following item.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826666
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2826744
Similar models
Concomitant medication
- StudyEvent: ODM
C2347852 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C2347804 (UMLS CUI [1,4])